SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cryoport, Inc. 
 TN
  SEC # 1124524


        
    Click to view...      Registrant      About      Filings      Files      Relationships      Names    
  Topics  
    Web       

202  Topics
Topic emoji
 within the 

Show:   Most-Recent Document   All Documents   And:   Exhibits  

 As Of  Filing  Doc.  Page    Title Docs.
  In ascending order
12/21/23424B31About This Prospectus
4/3/24New Filing!  DEF 14A1Audit Committee Report
3/13/2410-K1Business
4/3/24New Filing!  DEF 14A1Certain Relationships and Related Transactions
3/13/2410-K1Certain Relationships and Related Transactions, and Director Independence
1Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
12/21/23424B31Company, The
4/3/24New Filing!  DEF 14A1Compensation Committee Report
1Compensation Discussion and Analysis
8/9/2310-Q1Condensed Consolidated Balance Sheets at June 30, 2023 (Unaudited) and December 31, 2022
5/4/2310-Q1Condensed Consolidated Balance Sheets at March 31, 2023 (Unaudited) and December 31, 2022
11/9/2310-Q1Condensed Consolidated Balance Sheets at September 30, 2023 (Unaudited) and December 31, 2022
3/13/2410-K1Consolidated Balance Sheets as of December 31, 2023 and 2022
1Consolidated Statements of Cash Flows for the years ended December 31, 2023, 2022 and 2021
1Consolidated Statements of Comprehensive Loss for the years ended December 31, 2023, 2022 and 2021
1Consolidated Statements of Operations for the years ended December 31, 2023, 2022 and 2021
1Consolidated Statements of Stockholders' Equity for the years ended December 31, 2023, 2022 and 2021
1Controls and Procedures
4/3/24New Filing!  DEF 14A1Corporate Governance and Board Matters
3/13/2410-K1Cybersecurity
11/9/2310-Q1Defaults Upon Senior Securities
4/3/24New Filing!  DEF 14A1Delinquent Section 16(a) Reports
12/21/23424B31Description of Capital Stock
12/15/23POS AM1Description of Debt Securities
1Description of Depositary Shares
12/21/23424B31Description of Notes
12/15/23POS AM1Description of Purchase Contracts
1Description of Units
1Description of Warrants
4/3/24New Filing!  DEF 14A1Director Compensation
3/13/2410-K1Directors, Executive Officers and Corporate Governance
1Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
4/3/24New Filing!  DEF 14A1Election of Directors
1Equity Compensation Plan Information
1Executive Compensation
11/9/2310-Q1Exhibits
3/13/2410-K1Exhibits and Financial Statement Schedules
12/21/23424B31Experts
3/13/2410-K1Financial Statements and Supplementary Data
1Form 10-K Summary
4/3/24New Filing!  DEF 14A1Forward-Looking Statements
1Frequently Asked Questions
1General Information
12/15/23POS AM1Global Securities
4/3/24New Filing!  DEF 14A1Independent Registered Public Accounting Firm Fees
3/13/2410-K1Item 1
1Item 10
1Item 11
1Item 12
1Item 13
1Item 14
1Item 15
1Item 16
1Item 1A
1Item 1B
1Item 1C
1Item 2
1Item 3
1Item 4
1Item 5
1Item 6
1Item 7
1Item 7A
1Item 8
1Item 9
1Item 9A
1Item 9B
1Item 9C
12/21/23424B31Legal Matters
3/13/2410-K1Legal Proceedings
1Management's Discussion and Analysis of Financial Condition and Results of Operations
1Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
12/21/23424B31Material U.S. Federal Income Tax Consequences With Respect to the Common Stock to Non-U.S. Holders
1Material U.S. Federal Income Tax Consequences With Respect to the Notes
3/13/2410-K1Mine Safety Disclosures
11/9/2310-Q1Notes to Condensed Consolidated Financial Statements (Unaudited)
3/13/2410-K1Notes to Consolidated Financial Statements
1Other Information
4/3/24New Filing!  DEF 14A1Other Matters
1Ownership of Securities
3/13/2410-K1Part I
1Part Ii
11/9/2310-Q1Part Ii. Other Information
3/13/2410-K1Part Iii
1Part Iv
12/21/23424B31Plan of Distribution
3/13/2410-K1Principal Accountant Fees and Services
1Properties
4/3/24New Filing!  DEF 14A1Proposal 1
1Proposal 2
1Proposal 3
1Proposal 4
3/13/2410-K1Quantitative and Qualitative Disclosures About Market Risk
1Report of Independent Registered Public Accounting Firm
1Reserved
1Risk Factors
1Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
12/21/23424B31Selling Securityholders
3/13/2410-K1Signatures
12/21/23424B31Special Note Regarding Forward-Looking Statements
4/3/24New Filing!  DEF 14A1Stockholder Proposals for Next Annual Meeting
1Table of Contents
12/21/23424B31The Company
4/3/24New Filing!  DEF 14A1To approve an amendment to the Cryoport, Inc. 2018 Omnibus Equity Incentive Plan to increase the number of authorized shares for issuance thereunder
1To approve, on an advisory basis, the compensation of the named executive officers
1To ratify the appointment of Deloitte & Touche LLP
11/9/2310-Q1Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2023 and 2022
8/9/2310-Q1Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2023 and 2022
5/4/2310-Q1Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2023 and 2022
11/9/2310-Q1Unaudited Condensed Consolidated Statements of Comprehensive Loss for the three and nine months ended September 30, 2023 and 2022
8/9/2310-Q1Unaudited Condensed Consolidated Statements of Comprehensive Loss for the three and six months ended June 30, 2023 and 2022
5/4/2310-Q1Unaudited Condensed Consolidated Statements of Comprehensive Loss for the three months ended March 31, 2023 and 2022
11/9/2310-Q1Unaudited Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2023 and 2022
8/9/2310-Q1Unaudited Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2023 and 2022
5/4/2310-Q1Unaudited Condensed Consolidated Statements of Operations for the three months ended March 31, 2023 and 2022
11/9/2310-Q1Unaudited Condensed Consolidated Statements of Stockholders' Equity for the three and nine months ended September 30, 2023 and 2022
8/9/2310-Q1Unaudited Condensed Consolidated Statements of Stockholders' Equity for the three and six months ended June 30, 2023 and 2022
5/4/2310-Q1Unaudited Condensed Consolidated Statements of Stockholders' Equity for the three months ended March 31, 2023 and 2022
8/9/2310-Q1Unregistered Sales of Equity Securities and Use of Proceeds
11/9/2310-Q1Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities
3/13/2410-K1Unresolved Staff Comments
12/21/23424B31Use of Proceeds
1Where You Can Find More Information; Incorporation by Reference
4/3/24New Filing!  DEF 14A1100
1102
1103
1104

Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 1, 4:18:19.3pm ET